Sponsored by:
Federated Future: Back to the Science of Discovery
This Revvity webinar showcases how cutting-edge AI, machine learning, and integrated informatics platforms are transforming antibody discovery and developability assessment.
The session highlights advanced capabilities such as antibody numbering, sequence liability detection, structure prediction using deep learning models, and relative accessible surface area analysis to support informed candidate selection.
- State of AI in Signals
- Antibody Developability Dashboard
- ImmuneBuilder (ABodyBuilder2 – Oxford Protein Informatics Group)
